Lenacapavir

Otapa ningwa omalolelo gowenda tayi gandjwa lwaali momumvo okugamena aakiintu aagundjuka ko HIV

Omalolelo omanene ga ningwa mo South Africa nomo Uganda oguulike kutya owenda tayi gandjwa lwaali momvula otayi vulu okupa aakiintu aagundjuka egameno lyoo % 100 ko HIV. O SABC oya lopota kutya omalolelo otaga kongo oku tala ngele owenda yoomwedhi 6 yo lenacapavir otayi vulu okugandja egameno hwepo shi vulithe kiingangamithi yilwe yopaali,oopela hadhi nuwa lwaali mesiku ano o PrEP. Ospan yomapekapeko gopaunamiti okuza ko University of Cape town oya […]

25 July, 2024

World

HIV breakthrough: drug trial shows injection twice a year is 100% effective against infection

By Linda-Gail Bekker, University of Cape Town A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection. The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other drugs, both daily pills. All three medications are pre-exposure prophylaxis (or […]

3 July, 2024

Health / Medical

Pharma firm urged to share new ‘game-changer’ HIV drug

By Daniel Lawler Paris, May 30, 2024 (AFP) - More than 300 politicians, health experts and celebrities on Thursday called for US pharmaceutical giant Gilead to allow cheap, generic versions of a promising new HIV drug to be produced so it can reach people in developing countries most affected by the deadly disease. The drug lenacapavir could be a "real game-changer" in the fight against […]

30 May, 2024